S
Sumio Sugano
Researcher at University of Tokyo
Publications - 394
Citations - 34789
Sumio Sugano is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene & Complementary DNA. The author has an hindex of 76, co-authored 393 publications receiving 31681 citations. Previous affiliations of Sumio Sugano include Tokyo Medical and Dental University & Rockefeller University.
Papers
More filters
Journal ArticleDOI
Genome-wide profiling of the core clock protein BMAL1 targets reveals strict relationship with metabolism
Fumiyuki Hatanaka,Chiaki Matsubara,Jihwan Myung,Takashi Yoritaka,Naoko Kamimura,Shuichi Tsutsumi,Akinori Kanai,Yutaka Suzuki,Hiroyuki Aburatani,Sumio Sugano,Toru Takumi +10 more
TL;DR: It is reported that mice with a nervous system-specific deletion of Bmal1 (N-Bmal1−/− mice) had a severe deficit in entrainment of locomotor activity by periodic feeding, accompanied by reduced food intake and subsequent loss of body weight.
Journal ArticleDOI
A novel method for development of malaria vaccines using full-length cDNA libraries.
TL;DR: Mice vaccinated with a DNA vaccine consisting of 2000 pooled clones showed significantly prolonged survival after challenge infection and spleen cells of vaccinated mice produced augmented levels of IL-2 and IFN-gamma when incubated with the crude parasite antigens, indicating that cellular immunity plays an important role in the protection.
Journal ArticleDOI
Comprehensive analysis of gene expression profiles reveals novel candidates of chemotherapy resistant factors in canine lymphoma
Miyu Suenaga,Hirotaka Tomiyasu,Manabu Watanabe,Kotogo Ogawa,Tomoki Motegi,Yuko Goto-Koshino,Koichi Ohno,Sumio Sugano,Katherine A Skorupski,Hajime Tsujimoto +9 more
TL;DR: Novel molecular mechanisms of chemotherapy resistance by a comprehensive analysis of changes in gene expression profiles (GEPs) are identified in canine lymphoma at chemotherapy sensitive and chemotherapy resistant phases.
Journal ArticleDOI
Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
TL;DR: Xenograft examination in athymic nude mice demonstrated that TbetaRII-positive SW-13 cells reduced tumor-forming activity, and it was shown that Reconstructing the T betaRII can lead to reversion of the malignant phenotype of Tbeta RII-negative human adrenocortical carcinoma, which contains SW- 13 cells.
Journal ArticleDOI
Alteration of Immune Responses by N-acetylglucosaminyltransferase V during Allergic Airway Inflammation
Akiko Shibui,Aya Nambu,Aya Nambu,Eri Shimura,Sachiko Yamaguchi,Chiharu Shiraishi,Yoshitaka Sato,Ko Okumura,Sumio Sugano,Nobumichi Hozumi,Nobumichi Hozumi,Susumu Nakae +11 more
TL;DR: Mgat5-dependent glycosylation of proteins can modulate acquired immune responses, but it is not essential for the development of OVA-induced eosinophilic airway inflammation.